SCHEMBL10288609

SCHEMBL10288609

N#Cc1c(N2CCOCC2)sc(C(N)=O)c1C(F)(F)c1ccc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.50
PIK3R1 P27986 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
BTK Q06187 2/20 0.37
GRIA2 P42262 1/20 0.36
GRIA4 P48058 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PIN1 Q13526 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
AKR1C3 P42330 1/20 0.35
TNIK Q9UKE5 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10308589 0.92 PIK3CA (0.49) PIK3CAPIK3R1KDM4EALDH1A1MAPT
SCHEMBL10298505 0.85 PIK3CA (0.38) PIK3CAKDM4EALDH1A1MAPTBTK
SCHEMBL10288559 0.83 KDM4E (0.39) PIK3CAPIK3R1KDM4EALDH1A1MAPT
SCHEMBL623933 0.77 PIK3CA (0.52) PIK3CAKDM4EALDH1A1MAPTLMNA
SCHEMBL10298506 0.77 HSD17B10 (0.39) PIK3CAKDM4EALDH1A1MAPTBTK
SCHEMBL10288196 0.76 PIK3CA (0.41) PIK3CAPIK3R1KDM4EALDH1A1MAPT
SCHEMBL10288326 0.76 PIK3CA (0.66) PIK3CAPIK3R1KDM4EMAPTGRIA2
SCHEMBL10288561 0.72 PIK3CA (0.50) PIK3CAPIK3R1KDM4EMAPTGRIA2
SCHEMBL10288308 0.71 PIK3CA (0.49) PIK3CAPIK3R1KDM4EALDH1A1GRIA2
SCHEMBL10006318 0.70 PIK3CA (0.51) PIK3CAPIK3R1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3R1 1/4885KDM4E 4086/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3R1 1/4885KDM4E 4086/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3R1 1/4885KDM4E 3971/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885PIK3R1 1/4885KDM4E 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.